Developments toward a recombinant pertussis vaccine.
Burnette
W N
WN
Amgen Inc., Thousand Oaks, CA 91320.
Whiteley
D W
DW
Mar
V L
VL
Burns
D L
DL
Kaslow
H R
HR
Cieplak
W
W
Keith
J M
JM
Bartley
T D
TD
D003001:Cloning, Molecular; D006801:Humans; D010567:Pertussis Vaccine / Q000276:immunology; D011487:Protein Conformation; D014612:Vaccines / Q000276:immunology; D015164:Vaccines, Inactivated / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D010566:Virulence Factors, Bordetella / Q000235:genetics / Q000276:immunology
D010567:Pertussis Vaccine; D014612:Vaccines; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D010566:Virulence Factors, Bordetella